UniPharma Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 128.11 million compared to TWD 105.39 million a year ago. Net loss was TWD 6.45 million compared to TWD 74.41 million a year ago.

Basic loss per share from continuing operations was TWD 0.18 compared to TWD 2.11 a year ago. Diluted loss per share from continuing operations was TWD 0.18 compared to TWD 2.11 a year ago.